New hope for pregnant women battling opioid addiction: monthly shot vs daily pill

NCT ID NCT03918850

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested whether a once-monthly injection of buprenorphine works as well as daily pills to treat opioid use disorder in 140 pregnant women. The goal was to see if the monthly shot could reduce illicit opioid use during pregnancy and after birth. Results help doctors choose the best treatment for both mother and baby.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG ABUSE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Addiction Recovery Services (ARS), Swedish Medical Center

    Seattle, Washington, 98107, United States

  • Boston Medical Center

    Boston, Massachusetts, 02118, United States

  • CODA, Inc.

    Portland, Oregon, 97214, United States

  • Gateway Community Services

    Jacksonville, Florida, 32204, United States

  • Marshall Health MARC Program

    Huntington, West Virginia, 25701, United States

  • Massachusetts General Hospital HOPE Clinic

    Boston, Massachusetts, 02114, United States

  • Medical University of South Carolina

    Charleston, South Carolina, 29425, United States

  • Pregnancy Recovery Center at Magee-Womens Hospital of UPMC

    Pittsburgh, Pennsylvania, 15213, United States

  • University of Cincinnati Health Perinatal Addictions Program

    Cincinnati, Ohio, 45229, United States

  • University of New Mexico Milagro Clinic

    Albuquerque, New Mexico, 87106, United States

  • University of Utah SUPeRAD Clinic

    Salt Lake City, Utah, 84108, United States

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37232, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.